human immunoglobulin (pH4) for intravenous injection - Peking Union Medical College
Rituxan (rituximab) - Roche
EBV-associated autoimmune glial fibrillary acidic protein astrocytopathy with lumbosacral leptomeningeal enhancement: a case report and literature review. (PubMed, Neurol Sci) - Sep 16, 2026 - "EBV-associated GFAP-A can manifest as isolated lumbosacral leptomeningeal enhancement in the absence of classic intracranial radial perivascular enhancement. Combined antiviral and immunotherapy demonstrates favorable short-term efficacy, whereas long-term, B-cell-targeted maintenance therapy may reduce the risk of relapse." 
IO biomarker • Journal • Review • Back Pain • Epstein-Barr Virus Infections • Immunology • Infectious Disease • Lumbar Back Pain • Movement Disorders • Musculoskeletal Pain • Pain • GFAP
http://www.ncbi.nlm.nih.gov/pubmed/42742776
 
Hua Zhang; Huijing Liu; Huimin Chen; Jing He; Miaoxian Xie; Mingming Zhao; Shifang Hou; Yueying Liu; Zeyuan Zhang
 
Sep 16, 2026
 
Prev Next